Skip to main content
. 2021 May 29;15:11795468211015230. doi: 10.1177/11795468211015230

Figure 3.

Figure 3.

(A) Practices at amyloidosis centers related to repeated or missing diagnostic tests and (B) “hot spots” monitored by cardiologists in amyloidosis centers to help identify patients with undiagnosed ATTR-CM.

AL, light-chain amyloidosis; ATTR-CM, transthyretin amyloid cardiomyopathy; echo, echocardiogram; EHR, electronic health record; HFpEF, heart failure with preserved ejection fraction; ML, machine learning; MRI, magnetic resonance imaging; NLP, natural language processing; pts, patients; PYP, 99mtechnetium-pyrophosphate.